|Bid||205.75 x 1000|
|Ask||205.85 x 1000|
|Day's Range||205.05 - 210.54|
|52 Week Range||192.32 - 306.08|
|Beta (5Y Monthly)||0.79|
|PE Ratio (TTM)||26.00|
|Earnings Date||Oct 29, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||306.09|
Investors will be keen on updates from the recent study on its lead candidate, sumifilam, when Cassava (SAVA) reports Q3 results.
On Vertex's (VRTX) third-quarter earnings call, investor focus will be on the sales performance of its triple combo CF drug Trikafta and the probable impact of COVID-19 on the same.
What are the best ESG companies that lead their industry? We list the three high-ranking ESG stocks with the highest growth stock ratings in their business.